Mankind Pharma Limited has submitted a regulatory disclosure under Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding a change in the corporate office address of its Registrar and Share Transfer Agent (RTA).
The company's RTA, KFin Technologies Limited, has informed Mankind Pharma that it will be shifting its Corporate Office from its existing premises to a new location. This change will become effective from December 1, 2026.
Address Details
Existing Corporate Office Address:
KFin Technologies Limited,
Selenium Building, Tower-B, Plot No. 31 & 32,
Financial District, Nanakramguda,
Serilingampally, Hyderabad, Telangana 500032
New Corporate Office Address (effective December 1, 2026):
KFin Technologies Limited,
6th, 23rd, 24th, 25th Floor, South Tower,
Rajapushpa West Avenue, Survey No. 115,
Kokapet, Serilingampally Mandal,
Ranga Reddy District, Telangana-500075
Important Instructions
All investors and stakeholders are requested to note that with effect from December 1, 2026, all correspondence, notices, documents and other communications pertaining to the RTA must be addressed to the new Corporate Office address.
The company specifically notes that the Registered Office of KFin Technologies Limited remains unchanged despite this corporate office relocation.
The disclosure was signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer of Mankind Pharma Limited, on November 13, 2026.